Nassif David W. sold 6,000 Pharvaris shares at $36.47 each and later gifted 500 shares on Sep 21, 2026. For investors, the transactions set his reported ownership at 114,300 shares after the sale and 113,800 shares after the gift, equal to 5.0% and 0.4% of the respective prior holdings.
Key Highlights
- Nassif David W. sold 6,000 Pharvaris shares at $36.47 per share.
- The sale represented about 5.0% of his prior 120,300-share holding.
- A separate 500-share gift reduced his reported ownership to 113,800 shares.
Pharvaris Insider Transactions Detail
Pharvaris N.V. (NASDAQ: PHVS) is a biotechnology company. Its 6,000 shares amounted to about 5.0% of Nassif David W.’s previous total of 120,300 shares. The separate 500-share transfer carried code G, which denotes a gift. That gift represented about 0.4% of the 114,300 shares held before the transfer.
Reported Ownership Moves to 113,800 Shares
Nassif David W.’s reported ownership stood at 114,300 shares after the sale. It then fell to 113,800 shares following the gift. The two percentages are based on the holdings immediately preceding each transaction, with the sale measured against 120,300 shares and the gift against 114,300 shares.
FAQs
Q: What price did Nassif David W. receive for the Pharvaris share sale?
A: Nassif David W. sold 6,000 Pharvaris shares at $36.47 per share. The transaction took place on Sep 21, 2026.
Q: How many Pharvaris shares did Nassif David W. own after the transactions?
A: Reported ownership was 114,300 shares after the sale. Following the separate 500-share gift, ownership stood at 113,800 shares.
Q: What do transaction codes S and G mean in the Pharvaris insider report?
A: Code S identifies an open-market sale, while code G identifies a gift. Nassif David W. used those codes for the 6,000-share sale and 500-share transfer.
Download Free Report – Explore 3 Stock Ideas & Industry Insights
Unlock 3 stock ideas and key industry insights in our free report. This information is general in nature and does not consider your personal objectives, financial situation, or needs. It is not financial advice.
All investments involve risk—consider independent advice before making any investment decisions.
View 3 Research Reports
Disclaimer:
Kalkine Equities LLC, with Delaware File Number 4697384, Foreign Qualification Registration in California File Number 202109211078, and Texas File Number 805521396, is authorized to provide general advice only. The information on https://kalkine.com/ does not take into account any of your investment objectives, financial situation or needs. You should consider the appropriateness of advice taking into account your own objectives, financial situation and needs and seek independent financial advice before making any financial decisions. The link to our Terms and Conditions and Privacy Policy has been provided for your reference. On the date of publishing the reports (mentioned on the website), employees and/or associates of Kalkine do not hold positions in any of the stocks covered on the website. These stocks can change any time and readers of the reports should not consider these stocks as advice or recommendations later.